---
document_datetime: 2024-02-12 13:06:34
document_pages: 6
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/voraxaze-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: voraxaze-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 3.9859618
conversion_datetime: 2025-12-19 04:47:59.408193
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Voraxaze

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                           |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------------------------------|
| IB/0022              | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data) | 09/02/2024                          |                                             | SmPC                             |                                   |
| PSUSA/10968 /202307  | Periodic Safety Update EU Single assessment - glucarpidase                                                                                | 08/02/2024                          | n/a                                         |                                  | PRAC Recommendation - maintenance |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0024             | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                          | 29/01/2024   | n/a   |                                                                                                               |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|---------------------------------------------------------------------------------------------------------------|
| IA/0023             | B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method                                                                               | 10/11/2023   | n/a   |                                                                                                               |
| IA/0021/G           | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure | 05/10/2023   | n/a   |                                                                                                               |
| PSUSA/10968 /202301 | Periodic Safety Update EU Single assessment - glucarpidase                                                                                                                                                                                                                                          | 31/08/2023   | n/a   | PRAC Recommendation - maintenance                                                                             |
| IB/0019             | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                | 31/07/2023   | n/a   |                                                                                                               |
| IB/0018             | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                          | 07/07/2023   | n/a   |                                                                                                               |
| S/0013              | 1st annual re-assessment                                                                                                                                                                                                                                                                            | 25/05/2023   | n/a   | The CHMP, having reviewed the evidence of compliance with the specific obligations and the impact of the data |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                   |            |     | submitted by the MAH on the benefit/risk profile of the medicinal product, concluded that marketing authorisation of Voraxaze should be maintained.   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0016   | B.I.b.2.c - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure for a reagent, which does not have a significant effect on the overall quality of the AS                                                                                                                                                | 25/04/2023 | n/a |                                                                                                                                                       |
| IB/0012   | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                  | 20/03/2023 | n/a |                                                                                                                                                       |
| IA/0015/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 23/02/2023 | n/a |                                                                                                                                                       |
| IB/0014   | B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation                                                                                                                                                                                                                                                       | 15/02/2023 | n/a |                                                                                                                                                       |
| IB/0011   | B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation                                                                                                                                                                                                                                                       | 09/02/2023 | n/a |                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

| IB/0010             | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 09/02/2023   | n/a   |                                   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------------------|
| PSUSA/10968 /202207 | Periodic Safety Update EU Single assessment - glucarpidase                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 09/02/2023   | n/a   | PRAC Recommendation - maintenance |
| IB/0008             | B.II.d.z - Change in control of the Finished Product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 02/02/2023   | n/a   |                                   |
| IA/0009/G           | This was an application for a group of variations. B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor | 18/01/2023   | n/a   |                                   |
| IA/0007/G           | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 16/12/2022   | n/a   |                                   |

<div style=\"page-break-after: always\"></div>

|           | B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier   |            |     |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| II/0004   | B.I.b.1.f - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Change outside the approved specifications limits range for the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 22/09/2022 | n/a |
| IB/0003/G | This was an application for a group of variations. B.II.f.1.e - Stability of FP - Change to an approved stability protocol B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter B.II.d.1.d - Change in the specification parameters                                                                                                                                                                                                                                                                                                                                                                                   | 27/06/2022 | n/a |

<div style=\"page-break-after: always\"></div>

|         | and/or limits of the finished product - Deletion of a non-significant specification parameter                                                                                          |            |     |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| II/0002 | B.I.b.1.f - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Change outside the approved specifications limits range for the AS | 28/04/2022 | n/a |
| IB/0001 | B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation                                                                            | 03/03/2022 | n/a |